Skip to main content
Log in

Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): Protective effects of recombinant human interleukin-11

  • Published:
InflammoPharmacology Aims and scope Submit manuscript

Abstract

The objective of this study was to elucidate colonic mucosal ultrastructural effects of trinitrobenzene-sulphonic acid (TNBS) with and without co-administration of recombinant human interleukin-11 (rhIL-11). Using a standard colitis model (ir alcoholic TNBS), rats were sacrificed at 3~14 days after TNBS. Co-administration of rhIL-11 (100, 300 or 1000 μg/kg sc) was given for protection, and controls received saline or alcohol ir, or rhIL-11 sc alone. Transmission electron microscopy revealed that early TNBS-induced cytopathology was primarily in absorptive cells, changes which occurred prior to goblet cell damage. Progressive cellular changes included vacuolization and increased multivesicular bodies in cell apices, disconfiguration of microvilli, enlarged Golgi apparatuses, enlargement of basal inter-cellular spaces, and eventual desquamation of epithelium and apical bursting.

Organelle damage preceded surface changes and resembled ultrastructural changes reported for human ulcerative colitis. The principal effect of rhIL-11 was apparent massive release of mucus from goblet cells, filling the colonic crypts, and suggesting a mode of its protection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MacPherson B, Pfeiffer CJ. Experimental colitis. Digestion. 1976;14:424–52.

    PubMed  CAS  Google Scholar 

  2. Beeken WL. Experimental inflammatory bowel disease. In: Krisner JB, Shorter RG, eds. Inflammatory Bowel Disease. Philadelphia: Lea and Febiger; 1988:37–49.

    Google Scholar 

  3. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–67.

    Article  PubMed  CAS  Google Scholar 

  4. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803.

    PubMed  CAS  Google Scholar 

  5. Rampton DS. Colitis and nonsteroidal anti-inflammatory drugs. In: Domschke W, Dammann HG, eds. Prostaglandins and Leukotrienes in Gastrointestinal Diseases, Berlin: Springer-Verlag; 1988:254–9.

    Google Scholar 

  6. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacano JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 1989;97:326–37.

    PubMed  CAS  Google Scholar 

  7. Zeitlin IJ, Smith AN. Mobilization of tissue kallikreins in inflammatory diseases of the colon. Gut. 1973;14:133–8.

    PubMed  CAS  Google Scholar 

  8. Ekakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology. 1988;95:1167–72.

    Google Scholar 

  9. Kishimoto S, Kobayashi H, Shimizu S et al. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis. Dig Dis Sci. 1992;37:1729–37.

    Article  PubMed  CAS  Google Scholar 

  10. Keshavarzian A, Sedghi S, Kanofsky J et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992;103:177–85.

    PubMed  CAS  Google Scholar 

  11. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut. 1990;31:686–9.

    PubMed  CAS  Google Scholar 

  12. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the pro-inflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology. 1992;103:65–71.

    PubMed  CAS  Google Scholar 

  13. Mahida YR, Wu K, Patel S, Jewell DP. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol. 1988;74:382–6.

    PubMed  CAS  Google Scholar 

  14. Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Evidence for continuous stimulation of interleukin 6 production in Crohn's disease. Gastroenterology. 1992;102:514–9.

    PubMed  CAS  Google Scholar 

  15. Cominelli F, Nast CC, Llerena R, Dinarello CA, Zipser RD. Interleukin 1 suppresses inflammation in rabbit colitis. J Clin Invest. 1990;85:582–6.

    Article  PubMed  CAS  Google Scholar 

  16. Paul SR, Bennett F, Calvetti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl Acad Sci USA. 1990;87:7512–6.

    Article  PubMed  CAS  Google Scholar 

  17. Mckinley D, Wu Q, Yang-Feng T, Yang YC. Genomic sequence and chromosomal location of human interleukin (IL)-11 gene. Genomics. 1992;13:814–19.

    Article  PubMed  CAS  Google Scholar 

  18. Du XX, Doerschuk CM, Orazi A, Williams DA. A bone-marrow-stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood. 1994;83:33–7.

    PubMed  CAS  Google Scholar 

  19. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG. IL-11 a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells. 1994;12(Suppl. 1):79–90.

    PubMed  Google Scholar 

  20. Qiu BS, Pfeiffer CJ, Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNBS-induced colitis in rats. Dig Dis Sci. 1996;41:1625–30.

    Article  PubMed  CAS  Google Scholar 

  21. Pfeiffer CJ, Pfeiffer DC, Szabo S. Early ultrastructural changes in rat duodenal mucosa associated with cysteamine-induced ulcer. Exp Mol Pathol. 1987;46:102–13.

    Article  PubMed  CAS  Google Scholar 

  22. Pfeiffer CJ, Harding RK, Morris GP. Ultrastructural aspects of salicylate-induced damage to the gastric mucosa. In: Pfeiffer CJ, ed. Drugs and Peptic Ulcer, Vol. II. Boca Raton CRC Press; 1982:109–26.

    Google Scholar 

  23. Pfeiffer CJ, Dabareiner RM. Ultrastructure of Brunner's glands in the horse. J Submicrosc Cytol Pathol. 1992;24:581–8.

    PubMed  CAS  Google Scholar 

  24. Pfeiffer CJ, Rowden G, Weibel J. Gastrointestinal Ultrastructure: An Atlas of Scanning and Transmission Electron Microscopy. Stuttgart: G. Thieme, Publishers; 1974:265–83.

    Google Scholar 

  25. Florey HW. Electron microscopic observations on goblet cells of the rat's colon. Q J Exp Physiol. 1960;85:153–76.

    Google Scholar 

  26. Ono K. Ultrastructure of the surface principal cells of the large intestine in postnatal developing rats. Anat Embryol. 1976;149:155–71.

    Article  PubMed  CAS  Google Scholar 

  27. Reeve DRE. An electron microscopic study of chronic ulcers of the colon in rats. Br J Exp Pathol. 1977;58:63–77.

    PubMed  CAS  Google Scholar 

  28. Evangelista S, Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J Pharm Pharmacol. 1989:41:574–5.

    PubMed  CAS  Google Scholar 

  29. Donnellan WL. Early histological changes in ulcerative colitis, a light and electron microscopic study. Gastroenterology. 1966;50:519–40.

    PubMed  CAS  Google Scholar 

  30. Nagle GJ, Kurtz SM. Electron microscopy of the human rectal mucosa. A comparison of idiopathic ulcerative colitis with inflammation of known etiologies. Am J Dig Dis. 1967;12:541–67.

    Article  PubMed  CAS  Google Scholar 

  31. Pfeiffer CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition on TNBS-induced colitis in rats. J Pharm Pharmacol. 1995;47:827–32.

    PubMed  CAS  Google Scholar 

  32. Phillips TE, Wilson J. Morphometric analysis of mucous granule depletion and replenishment in rat colon. Dig Dis Sci. 1993;38:2299–304.

    Article  PubMed  CAS  Google Scholar 

  33. Tatsuta M, Yamamoto R, Iishi H, Nakaizumi A. Scanning electron microscopic observations on gastric mucus secretion in rats, and the effects of tetraprenylacetone. Digestion. 1995;56:175–80.

    Article  PubMed  CAS  Google Scholar 

  34. Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ. Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal anti-inflammatory drugs. A morphological study. Dig Dis Sci. 1993;38:730–9.

    Article  PubMed  CAS  Google Scholar 

  35. Pfeiffer CJ. Experimental analysis of hydrogen ion diffusion in gastrointestinal mucus glycoprotein. Am J Physiol. 1981;240:G176–82.

    PubMed  CAS  Google Scholar 

  36. Gross V, Andus T, Leser HG, Roth M, Scholmerich J. Inflammatory mediators in chronic inflammatory bowel diseases. Klin Wochenschr. 1991;69:981–7.

    Article  PubMed  CAS  Google Scholar 

  37. Kusugami K, Fukatsu A, Tanimoto M et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage and epithelial cell dependent. Dig Dis Sci. 199540:949–59.

    Article  PubMed  CAS  Google Scholar 

  38. Choi PM, Targan SR. Immunomodulator therapy in inflammatory bowel disease. Dig Dis Sci. 1994;39:1885–92.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeiffer, C.J., Sato, S., Qiu, B.S. et al. Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): Protective effects of recombinant human interleukin-11. Inflammopharmacol 5, 363–381 (1997). https://doi.org/10.1007/s10787-997-0033-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-997-0033-6

Keywords

Navigation